TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement 
OpenAI Explores Massive Funding Round at $750 Billion Valuation 
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties 
Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions 
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland 
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip 
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year 
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role 
Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling 
Micron Technology Forecasts Surge in Revenue and Earnings on AI-Driven Memory Demand 
Oracle Stock Slides After Blue Owl Exit Report, Company Says Michigan Data Center Talks Remain on Track 
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy 
Nike Shares Slide as Margins Fall Again Amid China Slump and Costly Turnaround 
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law 
ANZ New CEO Forgoes Bonus After Shareholders Reject Executive Pay Report 
Boeing Seeks FAA Emissions Waiver to Continue 777F Freighter Sales Amid Strong Cargo Demand 
Oracle Stock Surges After Hours on TikTok Deal Optimism and OpenAI Fundraising Buzz 
NEW YORK, Oct. 05, 2016 -- TPP Healthcare, a global advisory firm specializing in deal flows targeting China’s healthcare sector, announces its China Partnering Forum at AdvaMed 2016: The MedTech Conference for the second consecutive year. The forum will take place this month (October 17-19, 2016) at the Minneapolis Convention Center in Minnesota.
Concentrating in cross-border healthcare transactions, TPP aims to connect Chinese enterprises with North American and European companies seeking investment and licensing opportunities appropriate for China’s healthcare market. The TPP Healthcare China Partnering Forum at AdvaMed 2016 will feature TPP’s classic partnering event for attendees to meet one-on-one with Chinese healthcare companies and investment institutions.
In a change from previous events, the highlight of this year’s China Partnering Forum will be a series of exclusive information panels themed “China Capital Meets Overseas Innovation.” The panels will assist MedTech companies to better understand the Chinese market and avoid potential pitfalls from both business and legal perspectives. Industry player, Tony Chu, TPP Founding Partner, will be onsite hosting such panels and sharing his latest observation on healthcare cross-border activities. Also showcased will be “A High Level Overview on China MedTech Cross Border Activities,” a panel hosted by JC Sun, TPP Managing Director. Sun’s discussion will provide attendees insight on the latest trend and dynamics of China cross-border activities in the Medtech industry, discussing not only the transactions but also the operations afterwards.
The TPP Healthcare China Partnering Forum will also host an arrangement of industry veterans sharing real-life licensing cases in China during the sought out conference. Other participating panelists include:
- JSC Group
- Pagoda Investment Fund
- Huangzhou Kangyou Medical (HKM)
- HUGER Medical Instruments (HMI)
- CH-Gemstone Capital
- Jiangsu Juhe Science & Technology (JJST)
- Henan Shensheng Medical
- Maxhealth Medicine Group
- Jyton Group
Chu comments, “The time is now to invest in the growing Chinese market. This year’s panels and discussions will feature the most updated, in-depth observation on Chinese market dynamics and the prospect of China’s healthcare industry. Our core focus at TPP remains the same as every year, to utilize our expertise to create meaningful connections that will translate into successful business relationships.”
To meet with TPP Healthcare directly while at AdvaMed 2016, please contact Derrick Li at [email protected].
TPP Healthcare
The Pharma Partners (TPP) Healthcare is a global advisory firm that functions to capture the macroeconomic shift of China’s market interest in healthcare innovation by serving as a bridge between healthcare companies and investors from China and groundbreaking and innovative products and technologies from North America and Europe. Specializing in cross-border deal flow, TPP provides North American and European companies the access to capital, manufacturing, marketing and distribution in China.
About AdvaMed 2016: The MedTech Conference
AdvaMed 2016: The MedTech Conference is the leading gathering in North America of global MedTech executives with regulatory, reimbursement, business development, legal, IP, marketing, quality, compliance, HR and other key responsibilities. Along with industry leaders, the international conference attracts business development professionals, investors, policy-makers, members of the media, legal experts, consultants, distributors, and other important stakeholders.
More than 2,500 attendees will network, conduct business, gain access to capital and share insights in Minneapolis from October 17-19. The conference also features world-class plenary speakers, networking, and business development opportunities.
Visit http://advamed2016.com, follow @AdvaMedConf on Twitter, or join the AdvaMed Conference LinkedIn group to learn more.
PRESS CONTACT: Angela Byrne Director, Corporate Communications TPP Healthcare 750 Third Avenue, 9th Floor New York, NY 10017 Mobile: (217) 493 7108 E-Mail: [email protected]
